Fig. 2From: Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyMean change from baseline at weeks 24 and 48 in patients with moderate to severe LUTS and prostate cancer receiving triptorelin therapy. a Total IPSS, (b) IPSS obstructive (voiding) subscore, (c) IPSS irritative (storage) subscore. Error bars represent standard deviations. IPSS, International Prostate Symptoms Score; LUTS, lower urinary tract symptomsBack to article page